Sessions Will Help Psychiatrists Treat HIV/AIDS Patients

A 40-year-old HIV-positive man, with an undetectable viral load, a CD4 count in the 600s, and an occasional user of ecstasy and alcohol is referred to you for low energy and memory difficulties. Do you know the differential diagnoses and what to do next?

With increasing frequency, primary care clinicians are recognizing the neuropsychiatric and psychiatric sequelae of HIV infection. With more than 1 million people infected with HIV in the United States, chances are that psychiatrists will be asked to play a role in their health care.

The following symposia and component workshop developed by the APA Committee on AIDS will provide an overview of the complexities psychiatrists face in treating patients with HIV and AIDS:

TUESDAY, MAY 22

11 a.m.-12:30 p.m.

HIV and Metabolic Syndrome

Component workshop

Room 28A, Upper Level, San Diego Convention Center

Metabolic abnormalities significantly affect the quality of life of patients living with HIV/AIDS. This session will help psychiatrists understand the physical and psychological effects of these abnormalities on patients, including metabolic issues, bodily discomfort, low self-esteem, depression, sexual dysfunction, social isolation, and reduced treatment adherence.

2 p.m.-5 p.m.

HIV and AIDS Pandemic: Changes in Populations, Perceptions, Practices, and Promises

Symposium

Room 30A, Upper Level, San Diego Convention Center

The role of psychiatrists is evolving every day. Learn how you can impact the quality of life and improve the mental health of your HIV-positive patients. Experts in the field will review the domestic and global impact of HIV/AIDS and highlight important advances in HIV prevention and treatment. Panelists will discuss who is most affected by HIV/AIDS today and the changing role of psychiatrists on the treatment team.

WEDNESDAY, MAY 23

2 p.m.-5 p.m.

HIV Update for Psychiatric Care

Symposium

Room 32A, Upper Level, San Diego Convention Center

A panel of experts will review medical advances in HIV/AIDS, evidence-based treatments in HIV-related psychiatric disorders, and the challenges in treating HIV as a lifelong illness. There will also be a focus on understanding the complex psychiatric illnesses facing patients with HIV/AIDS.